MTOR and breast cancer: The results showed that the upregulation of AKT/mTOR pathway, overexpression of miR-125b or the silencing of miR-424 expression predispose the BC cells to acquire resistance to letrozole and anastrozole compared to control group (Vilquin et al., 2015; Zedain et al., 2020).